Beta Bionics, Inc. · NASDAQ:BBNX

Feider Stephen sold 382 Beta Bionics, Inc. shares (Form 4)

Traded Nov 5, 2026 · Filed Nov 9, 2026

On Nov 5, 2026, Feider Stephen (Chief Financial Officer) sold 382 Beta Bionics, Inc. shares at US$17.04 for US$6,508 under a trading plan, leaving 159,378 shares. Filed Nov 9, 2026 (Form 4).

Sold
382 shares
Price
US$17.04
Value
US$6,508
Holding after
159,378 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 5, 2026Common StockOption exercise382US$5.10159,760Direct
Nov 5, 2026Common StockSale382US$17.04159,378Direct

Source

Download original · View original at SEC

Related